NCT05854394

Brief Summary

The process of enhancing an individual's functional capacity to optimize physiologic reserves before an operation to withstand the stress of surgery has been coined prehabilitation. This is a prospective randomized controlled trail, designed to explore if the patients who take Colorectal Cancer Surgery will benefit from short-term multimodal prehabilitation strategy. multimodal prehabilitation includes exercise, nutrition supplement and physiology management preoperatively. It starts from the day that patients decide to take the surgery until the day before surgery, lasting 1\~2 week in The First Affiliated Hospital of Xiamen University. And investigators follow-up patients until 4 weeks after surgery to investigate if multimodal prehabilitation strategy can improve the postoperative functional recovery and improve the quality of life #reduce complications and improve prognosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P25-P50 for not_applicable colorectal-cancer

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable colorectal-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2023

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

April 25, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 11, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

May 11, 2023

Status Verified

May 1, 2023

Enrollment Period

8 months

First QC Date

April 25, 2023

Last Update Submit

May 10, 2023

Conditions

Keywords

PrehabilitationQuality of lifeCancer-related fatigueColorectal cancer

Outcome Measures

Primary Outcomes (1)

  • 6-minute-walking-distance (6MWD)

    Use 6-minute-walking-distance (6MWD) to evaluate the physical functional capability objectively.

    [Time Frame: 4 weeks postoperatively]

Secondary Outcomes (2)

  • Cancer-related fatigue

    [Time Frame: 4 weeks postoperatively]

  • Quality of Life Scale

    [Time Frame: 4 weeks postoperatively]

Study Arms (2)

Prehabilitation group

EXPERIMENTAL

Multimodal prehabilitation strategy includes physical exercise (moderate aerobic exercise combined with resistance exercise and respiratory training ), nutritional suggestion and optimization#whey protein supplement#, and psychological therapy, as well as conventional guidance (including drug treatment recommendations for chronic disease, quit smoking and abstinence).

Behavioral: Multimodal prehabilitation management Multimodal prehabilitation management

Control group

NO INTERVENTION

The patients will receive the conventional clinical guidance according to The First Affiliated Hospital of Xiamen University, including drug treatment recommendations for chronic disease, quit smoking and abstinence.

Interventions

Multimodal prehabilitation strategy includes physical exercise (moderate aerobic exercise combined with resistance exercise ), nutritional suggestion and optimization(whey protein supplement), and psychological therapy, as well as conventional guidance (including drug treatment recommendations for chronic disease, quit smoking and abstinence).

Prehabilitation group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • From 18 y/o to 75 y/o
  • Suspected of colorectal cancer
  • Decide to take the colorectal cancer radical surgery in The First Hospital Affiliated to Xiamen University
  • Patients with post-operative pathological diagnosis of colorectal cancer

You may not qualify if:

  • Refuse or fail to cooperate the study (due to any reason)
  • Unable to tolerate prehabilitaion strategy (including exercise guide, whey protein and psycho-relaxation exercise)
  • Other severe cardio-pulmonary diseases that would affect the 6MWD

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Xiamen University

Xiamen, FuJian Provice, 361000, China

RECRUITING

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Central Study Contacts

JiaJun Zhang, Master of Medicine

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: patients were randomly assigned to the prehabilitation group and control group by online randomization software
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 25, 2023

First Posted

May 11, 2023

Study Start

April 1, 2023

Primary Completion

December 1, 2023

Study Completion

December 31, 2023

Last Updated

May 11, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations